The HIGH Horizons project aims to identify cost-effective, integrated adaptation-mitigation interventions to alleviate heat impacts on health workers, and to reduce carbon emissions associated with health care.
7th National Batho Pele Excellence awarded to Professor Helen Rees
Unitaid to introduce new long-lasting injection to prevent HIV in Brazil and South Africa, as high-income countries begin deployment
This accolade recognises her outstanding medical career and commitment to improving global health with a focus on public health in Africa
The GPEI is supporting health authorities in Malawi to conduct a thorough assessment of the situation and begin urgent immunization activities in the subregion to mitigate any risk of spread
Results of REACH study suggests monthly dapivirine vaginal ring would be a viable option for those who can’t or choose not to use daily oral PrEP, researchers report at CROI
ViiV Healthcare announces US FDA approval of Cabenuva (cabotegravir, rilpivirine) for use every two months, expanding the label of the first and only complete long-acting HIV treatment
Drug Given Every Two Months Rather Than Daily Pill is Important Tool in Effort to End the HIV Epidemic in Africa
A new US$85 million program to help women in multiple countries in sub-Saharan Africa protect themselves from HIV has been launched, MOSAIC (Maximizing Options to Advance Informed Choice for HIV Prevention), is implemented by a consortium of partners led by FHI 360 with a range of local partners. Wits RHI is part of the core strategic leadership group for all consortium activities.
Interim results of the REACH study of daily oral PrEP and monthly dapivirine vaginal ring presented at IAS 2021 – the 11th IAS Conference on HIV Science